CHRNA7 and Alzheimer disease: It has been reported that GTS-21 has been used in clinical trials to target neuronal α7nAChR in the brain of patients with Alzheimer's disease [47], since the cholinergic anti-inflammatory pathway is activated by stimulating the α7nAChR [33].